I 
117TH CONGRESS 
2D SESSION 
H. R. 8976 
To preempt State restrictions on dispensing mifepristone or misoprostol, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 22, 2022 
Mr. RYAN of New York introduced the following bill; which was referred to 
the Committee on Energy and Commerce 
A BILL 
To preempt State restrictions on dispensing mifepristone or 
misoprostol, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Protecting Reproduc-
4
tive Freedom Act’’. 
5
SEC. 2. PREEMPTION OF STATE RESTRICTIONS ON DIS-
6
PENSING MIFEPRISTONE AND MISOPROSTOL. 
7
No State may establish, implement, or enforce— 
8
VerDate Sep 11 2014 
21:56 Oct 05, 2022
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8976.IH
H8976
kjohnson on DSK79L0C42PROD with BILLS
2 
•HR 8976 IH
(1) any prohibition or restriction on shipping or 
1
sending mifepristone or misoprostol across State 
2
lines; 
3
(2) any requirement that mifepristone or 
4
misoprostol be dispensed by a health care practi-
5
tioner in person; or 
6
(3) any prohibition or restriction on prescribing 
7
or dispensing mifepristone or misoprostol by means 
8
of telehealth. 
9
SEC. 3. REPORT. 
10
Not later than 30 days after the date of enactment 
11
of this Act, the Secretary of Health and Human Services, 
12
acting through the Commissioner of Food and Drugs, 
13
shall submit a report to the Congress on ways to expand 
14
access to abortion medication. 
15
SEC. 4. DEFINITIONS. 
16
In this Act: 
17
(1) 
The 
term 
‘‘mifepristone’’ 
means 
18
mifepristone that is— 
19
(A) approved under subsection (c) or (j) of 
20
section 505 of the Federal Food, Drug, and 
21
Cosmetic Act (21 U.S.C. 355); 
22
(B) indicated for medical abortion; and 
23
(C) subject to a risk evaluation and mitiga-
24
tion strategy under section 505–1 of the Fed-
25
VerDate Sep 11 2014 
21:56 Oct 05, 2022
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8976.IH
H8976
kjohnson on DSK79L0C42PROD with BILLS
3 
•HR 8976 IH
eral Food, Drug, and Cosmetic Act (21 U.S.C. 
1
355–1). 
2
(2) The term ‘‘misoprostol’’ means misoprostol 
3
that is— 
4
(A) approved under subsection (c) or (j) of 
5
section 505 of the Federal Food, Drug, and 
6
Cosmetic Act (21 U.S.C. 355); 
7
(B) indicated for medical abortion; and 
8
(C) subject to a risk evaluation and mitiga-
9
tion strategy under section 505–1 of the Fed-
10
eral Food, Drug, and Cosmetic Act (21 U.S.C. 
11
355–1). 
12
Æ 
VerDate Sep 11 2014 
21:56 Oct 05, 2022
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H8976.IH
H8976
kjohnson on DSK79L0C42PROD with BILLS
